Tralokinumab in Combination With Topical Corticosteroids in Subjects With Severe Atopic Dermatitis Who Are Not Adequately Controlled With or Have Contraindications to Oral Cyclosporine A

Condition:   Atopic Dermatitis Interventions:   Drug: Tralokinumab;   Other: Placebo Sponsor:   LEO Pharma Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials